药物开发 药物开发
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
这项研究表明,微质中SIGLEC10表达的增加有助于导致阿尔茨海默氏症 (AD) 病变. 用抗体向SIGLEC10显著减少了关键的AD病理,包括神经纤维状结和粉样斑块.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 全基因组关联研究将Siglec基因与晚发性阿尔茨海默病 (AD) 联系起来.
- SIGLEC10在大脑微质中高度表达,在AD中升高.
- 之前的研究缺乏关于SIGLEC10和AD病因之间的因果关系的数据.
研究的目的:
- 调查SIGLEC10在阿尔茨海默氏症 (AD) 病原发生中的作用.
- 为了确定SIGLEC10表达和AD特征之间的因果关系.
主要方法:
- 创建了表达人类SIGLEC10的转基因小鼠,并将它们与缺少SiglecG的小鼠交叉.
- 使用免疫组织化学评估了粉样β (Aβ) 斑块和酸化的tau神经纤维状 (NFTs).
- 服用抗SIGLEC10抗体,以确认其对病理学的贡献.
主要成果:
- 转基因小鼠在9-13个月后显示NFT和Aβ斑块增加.
- 微质细胞在大脑中专门表达人类的SIGLEC10.
- 抗SIGLEC10抗体治疗显著减少了NFT和Aβ斑块的积累.
结论:
- 微质中SIGLEC10的转基因表达加剧了AD的NFT和Aβ斑块标志.
- 在小鼠模型中,抗SIGLEC10治疗有效地减少了这些病理.
- 这项研究确定了SIGLEC10和晚期发病的AD病原体之间的因果关系.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
